196 related articles for article (PubMed ID: 29360580)
21. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
[TBL] [Abstract][Full Text] [Related]
22. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
[TBL] [Abstract][Full Text] [Related]
23. Discovery of biomarkers for endometrial cancer: current status and prospects.
Rižner TL
Expert Rev Mol Diagn; 2016 Dec; 16(12):1315-1336. PubMed ID: 27817223
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Diagnostic Accuracies of Serum HE-4 Levels and 3D Power Doppler Angiography Parameters between Benign Endometrial Pathologies and Endometrial Cancer.
Erenel H; Bese T; Sal V; Demirkiran F; Arvas M
Asian Pac J Cancer Prev; 2016; 17(5):2507-11. PubMed ID: 27268621
[TBL] [Abstract][Full Text] [Related]
25. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
[TBL] [Abstract][Full Text] [Related]
26. Preoperative Magnetic Resonance Volumetry in Predicting Myometrial Invasion, Lymphovascular Space Invasion, and Tumor Grade: Is It Valuable in International Federation of Gynecology and Obstetrics Stage I Endometrial Cancer?
Sahin H; Sarioglu FC; Bagci M; Karadeniz T; Uluer H; Sanci M
Int J Gynecol Cancer; 2018 May; 28(4):666-674. PubMed ID: 29697491
[TBL] [Abstract][Full Text] [Related]
27. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
28. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer.
Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I
Clin Chim Acta; 2018 Jun; 481():108-114. PubMed ID: 29481776
[TBL] [Abstract][Full Text] [Related]
30. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
31. Serum lipidome screening in patients with stage I non-small cell lung cancer.
Klupczynska A; Plewa S; Kasprzyk M; Dyszkiewicz W; Kokot ZJ; Matysiak J
Clin Exp Med; 2019 Nov; 19(4):505-513. PubMed ID: 31264112
[TBL] [Abstract][Full Text] [Related]
32. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
[TBL] [Abstract][Full Text] [Related]
33. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
[TBL] [Abstract][Full Text] [Related]
34. Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker.
Ihata Y; Miyagi E; Numazaki R; Muramatsu T; Imaizumi A; Yamamoto H; Yamakado M; Okamoto N; Hirahara F
Int J Clin Oncol; 2014 Apr; 19(2):364-72. PubMed ID: 23700142
[TBL] [Abstract][Full Text] [Related]
35. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.
Qiu Y; Zhou B; Su M; Baxter S; Zheng X; Zhao X; Yen Y; Jia W
Int J Mol Sci; 2013 Apr; 14(4):8047-61. PubMed ID: 23584023
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
37. Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium.
Geijsen AJMR; van Roekel EH; van Duijnhoven FJB; Achaintre D; Bachleitner-Hofmann T; Baierl A; Bergmann MM; Boehm J; Bours MJL; Brenner H; Breukink SO; Brezina S; Chang-Claude J; Herpel E; de Wilt JHW; Gicquiau A; Gigic B; Gumpenberger T; Hansson BME; Hoffmeister M; Holowatyj AN; Karner-Hanusch J; Keski-Rahkonen P; Keulen ETP; Koole JL; Leeb G; Ose J; Schirmacher P; Schneider MA; Schrotz-King P; Stift A; Ulvik A; Vogelaar FJ; Wesselink E; van Zutphen M; Gsur A; Habermann N; Kampman E; Scalbert A; Ueland PM; Ulrich AB; Ulrich CM; Weijenberg MP; Kok DE
Int J Cancer; 2020 Jun; 146(12):3256-3266. PubMed ID: 31495913
[TBL] [Abstract][Full Text] [Related]
38. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
[TBL] [Abstract][Full Text] [Related]
39. Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam study.
Bachlechner U; Floegel A; Steffen A; Prehn C; Adamski J; Pischon T; Boeing H
Nutr Diabetes; 2016 Jun; 6(6):e215. PubMed ID: 27348203
[TBL] [Abstract][Full Text] [Related]
40. Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.
Zeng X; Zhang Z; Gao QQ; Wang YY; Yu XZ; Zhou B; Xi MR
Dis Markers; 2016; 2016():9262919. PubMed ID: 27340318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]